BAC and Octapharma extend collaboration for G-CSF custom ligand
August 17, 2010Manufacturing and Production BAC, Octapharma
BAC, a specialist in antibody-based affinity purification technology has signed a licence agreement with Octapharma, which manufactures human proteins for …
FDA considers pulling ProAmantine
August 17, 2010Sales and Marketing FDA, Shire, post-marketing
Shire’s low blood pressure drug ProAmantine and generic copies could be withdrawn from the US market because no post-marketing studies …
AstraZeneca staff to strike over pension cuts
August 17, 2010Sales and Marketing AstraZeneca, pensions
AstraZeneca is reviewing its position after UK trade union members at the company voted to strike over cuts to pension …
Digital Pharma: Roche asks employees to be social media ‘scouts’
August 17, 2010Medical Communications Digital Pharma blog, Roche, social media
Roche wants employees who use social media to be ‘scouts’ for how the company and its products are perceived online. …
Biocatalyst firm Codexis posts sales increase
August 16, 2010Manufacturing and Production Codexis, biocatalyst
Codexis has reported a healthy increase in revenues in the second quarter of 2010 which suggests that pharmaceutical companies are …
Patient group sponsorship and transparency criticised
August 16, 2010Sales and Marketing EMA, ethics, patient groups, transparency
High rates of sponsorship from pharma groups for patient groups have been criticised in a new report. The report from …
Regenerative medicine: small steps towards the great leap forward
August 16, 2010Research and Development GSK, Pfizer, Stem cells, regenerative medicine
Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …
Merck signs Alzheimer’s deal with Alectos
August 16, 2010Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co
Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
Emergency contraceptive proves controversial in US
August 16, 2010Sales and Marketing Ella, Plan B, Watson, emergency contraceptive
The FDA has approved HRA Pharma’s emergency contraceptive pill Ella but has been criticised by conservative ‘pro-life’ groups. French company …
PharmaIntel appoints Demitri Gabrielides
August 16, 2010Sales and Marketing PharmaIntel, appointment, sales and marketing
Commercial excellence agency PharmaIntel has appointed Demitri Gabrielides to the role of business partner.He has over 20 years experience in key …
Ranbaxy chief executive steps down
August 13, 2010Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy
The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …
Digital Pharma: Pfizer begins social media drive for online clinic
August 13, 2010Medical Communications Digital Pharma blog, ManMOT, Pfizer, Twitter, digital patients
Pfizer UK has turned to social media to help raise awareness of its online Man MOT male health clinic and …
Grey Healthcare Group expands
August 13, 2010Medical Communications Grey, medical communications
Grey Healthcare Group has expanded its European operations and boosted its animal health expertise with the acquisition of Geoff Howe …
Gilead is latest drugmaker in FDA’s sights
August 13, 2010Manufacturing and Production Gilead, cystic fibrosis, manufacturing compliance
A manufacturing and distribution facility operated by US biotech Gilead Sciences is at risk of receiving a warning letter from …
Brand and deliver: standing out in the healthcare climate
August 13, 2010Medical Communications Spink, self care
The ongoing drive towards increased self care is placing healthcare consumers even more firmly behind the steering wheel. But how …
Pharma manufacturing news in brief
August 13, 2010Manufacturing and Production Dutch CMO SynCo Bio Partners, GeoPharma, Merck & Co, Positron, SCM Pharma, Thermo Fisher Scientifitic
EMA and FDA issue call for volunteers for joint inspection pilot, plus facility updates from Merck & Co, Thermo Fisher …
Amgen’s Vectibix fails late stage trial
August 12, 2010Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer
Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
Online multidisciplinary library goes live
August 12, 2010Medical Communications Cochrane, Wiley, Wiley-Blackwell, evidence-based medicine
A new online resource offering access to one of the world’s most extensive multidisciplinary collections of resources for health, physical …
WHO sounds swine flu all clear
August 12, 2010Sales and Marketing WHO, h1n1, swine flu
The world is no longer in the grips of an H1N1 pandemic and the virus has run its course according …
GPs in the driving seat for ‘clinical commissioning’
August 12, 2010GP, NHS, PCT, government
The reforms of the NHS unveiled in July will have a radial impact on how the service is run, giving …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
